LJI study suggests future asthma therapies need to target two key immune molecules (IMAGE)

La Jolla Institute for Immunology

LJI study suggests future asthma therapies need to target two key immune molecules

Caption

Left: Lung tissue of untreated mice. Right: Lung tissue of mice treated with antibodies blocking OX40L and CD30L.

Credit

Dr. Gurupreet Sethi, La Jolla Institute for Immunology.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.